Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09HAL
|
||||
| Former ID |
DIB005734
|
||||
| Drug Name |
JTT-651
|
||||
| Synonyms |
Glycogen phosphorylase inhibitor (oral, diabetes) Japan Tobacco
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 1 | [1] | ||
| Company |
Japan Tobacco Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Glycogen phosphorylase, muscle form | Target Info | Inhibitor | [2] | |
| BioCyc Pathway | Glycogenolysis | ||||
| KEGG Pathway | Starch and sucrose metabolism | ||||
| Metabolic pathways | |||||
| Insulin signaling pathway | |||||
| Glucagon signaling pathway | |||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| WikiPathways | Glycogen Metabolism | ||||
| Metabolism of carbohydrates | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026877) | ||||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026877) | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.